More than £2m has been raised by partners at Goldman Sachs to finance a new treatment and research facility at a leading cancer hospital.

The cash boost follows an appeal from The Royal Marsden Cancer Charity to fund a new department within the Oak Cancer Centre at The Royal Marsden Hospital in Sutton.

The Goldman Sachs Gives Centre for Urgent Care will target patients who become unwell due to their symptoms, or who are experiencing side effects from treatment. 

This model of care, developed by The Royal Marsden, means patients avoid unnecessary hospital admissions.

Under one roof

The Royal Marsden Cancer Charity has committed to raising £70m to fund the Oak Cancer Centre, which will bring researchers, clinicians, and patients together under one roof. 

It has been designed to encourage collaboration and to speed up the translation of world-leading research into breakthroughs in treatment and care for patients, not just at The Royal Marsden, but throughout the UK and further afield.

The Goldman Sachs Gives Centre for Urgent Care will inform this innovative ‘bench-to-bedside’ drug development process as the side effects of patients attending the department will be closely monitored and treated, helping researchers assess new treatments. 

It will also expand and modernise the hospital’s existing service, quadrupling the number of patients who can be seen at any one time. 

Antonia Dalmahoy, managing director of The Royal Marsden Cancer Charity, said: “On behalf of the charity, I would like to say a huge thank you to everyone who has supported us through Goldman Sachs Gives to help us reach this incredible milestone; we are so grateful for their tireless support. 

Supporting innovation

“This generous donation takes us a big step closer to making the Oak Cancer Centre a reality, funding a department which will be a cornerstone of patient care within the facility.

“Instead of attending their local A&E, the Goldman Sachs Gives Centre for Urgent Care will offer patients with sudden or serious symptoms from treatment a discreet and dedicated space to be supported by cancer experts, ensuring the care and treatment they receive is specialised and tailored to them.”

Richard Cormack, partner at Goldman Sachs and Appeal Board member for The Royal Marsden’s new Oak Cancer Centre, adds:

“It’s a real honour to know we’re funding a vital department in the Oak Cancer Centre, which will make a huge difference to the lives of cancer patients across the world.”

The Oak Cancer Centre has been designed by BDP and is being built by ISG.